Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Decitabine Activity Against TP53 -Mutated Myeloid Neoplasms Is Enhanced By Combination with a Non-Cytotoxic p53/BAX-Independent Inhibitor of Pyrimidine Synthesis

Sudipta Biswas, Zeinab Albadry M. Zahran, Xiaorong Gu, Lisa Cardone, Akriti G. Jain, Kateryna Fedorov, Ben K. Tomlinson, Mendel Goldfinger, Amit Verma, Yogenthiran Saunthararajah

Blood (2024) 144 (Supplement 1): 1382.

https://doi.org/10.1182/blood-2024-210609

Published: 2024

Journal Articles

FLT3-ITD Signaling Continuously Degrades p53 By the Ubiquitin-Proteosome Pathway Explaining Chemo-Resistance

Xiaorong Gu, Zeinab Albadry M. Zahran, Ramesh Balusu, Jaroslaw Maciejewski, Babal K. Jha, Yogenthiran Saunthararajah

Blood (2024) 144 (Supplement 1): 2714.

https://doi.org/10.1182/blood-2024-205887

Published: 2024

Journal Articles

BCR-ABL1 Dislocates NPM1, PU.1 and KLF1 into Cytoplasm to Thereby Skew Granulo-Monocytic and Impede Erythroid Differentiation

Zeinab Albadry M. Zahran, Xiaorong Gu, Babal K. Jha, Yogenthiran Saunthararajah

Blood (2023) 142 (Supplement 1): 1375.

https://doi.org/10.1182/blood-2023-187016

Published: 2023

Journal Articles

FLT3-ITD Degrades CEBPA Via the Ubiquitin-Proteosome Pathway

Xiaorong Gu, Zeinab Albadry M. Zahran, Nneha Sakre, Caroline Schuerger, Yogenthiran Saunthararajah

Blood (2022) 140 (Supplement 1): 2993–2994.

https://doi.org/10.1182/blood-2022-166612

Published: 2022